These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28480767)

  • 21. Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors.
    Barcellos CR; Rocha MP; Hayashida SA; Dantas WS; Dos Reis Vieira Yance V; Marcondes JA
    Hormones (Athens); 2015; 14(2):251-7. PubMed ID: 26158655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate-resistant polycystic ovarian syndrome patients.
    Bjelica A; Trninić-Pjević A; Mladenović-Segedi L; Cetković N; Petrović D
    Srp Arh Celok Lek; 2016; 144(3-4):146-50. PubMed ID: 27483558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased oxidative stress is associated with thiol/disulphide homeostasis in clomiphene citrate resistant polycystic ovary syndrome.
    Ege S; Bademkıran MH; Peker N; Özgün Z; Bağlı İ; Erdem S; Erel Ö; Özgökçe Ç; Gül E
    J Obstet Gynaecol; 2021 Apr; 41(3):467-470. PubMed ID: 32586152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome.
    Kocak M; Caliskan E; Simsir C; Haberal A
    Fertil Steril; 2002 Jan; 77(1):101-6. PubMed ID: 11779598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
    Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome.
    Lee H; Oh JY; Sung YA
    Korean J Intern Med; 2013 Jul; 28(4):456-63. PubMed ID: 23864804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome.
    Sönmez AS; Yasar L; Savan K; Koç S; Ozcan J; Toklar A; Yazicioğu F; Akgün A; Sut N
    Hum Reprod; 2005 Jan; 20(1):175-9. PubMed ID: 15513975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries.
    Anttila L; Koskinen P; Kaihola HL; Erkkola R; Irjala K; Ruutiainen K
    Fertil Steril; 1992 Oct; 58(4):697-702. PubMed ID: 1426312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome.
    Nemati M; Nemati S; Taheri AM; Heidari B
    J Gynecol Obstet Hum Reprod; 2017 Sep; 46(7):579-585. PubMed ID: 28698075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progranulin and tumor necrosis factor-alpha in lean polycystic ovary syndrome patients.
    Uzdogan A; Kuru Pekcan M; Cil AP; Kisa U; Akbiyik F
    Gynecol Endocrinol; 2021 Oct; 37(10):925-929. PubMed ID: 34338562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial.
    Palomba S; Falbo A; Giallauria F; Russo T; Rocca M; Tolino A; Zullo F; Orio F
    Hum Reprod; 2010 Nov; 25(11):2783-91. PubMed ID: 20858697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Misso ML; Costello MF; Garrubba M; Wong J; Hart R; Rombauts L; Melder AM; Norman RJ; Teede HJ
    Hum Reprod Update; 2013; 19(1):2-11. PubMed ID: 22956412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    Franik S; Kremer JA; Nelen WL; Farquhar C
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
    Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
    Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose, insulin and C-peptide secretion in obese and non obese women with polycystic ovarian disease.
    Mahabeer S; Naidoo C; Joubert SM
    Diabetes Res; 1990 Jun; 14(2):79-82. PubMed ID: 2134217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy in infertile PCOD patients. Complications and outcome.
    Urman B; Sarac E; Dogan L; Gurgan T
    J Reprod Med; 1997 Aug; 42(8):501-5. PubMed ID: 9284012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.